A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 40
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
COMING SOON: End of March
2026 IOL Market Report: Global Analysis for 2025 to 2031, March, 2026
The “2026 IOL Market Report” delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today’s landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning.
Built on Market Scope’s proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market.
The analysis segments the market across 11 distinct IOL categories—commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs— to provide a clear view of where growth is occurring and how the premium market continues to evolve.
In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market.
Latest Industry News & Trends
3/20/2026
BreakingCataractDealsFLACSSurgical
Alcon, Lensar Scrap Acquisition Deal in Face of FTC Opposition
Alcon and Lensar reported March 16 that they were terminating Alcon’s $430 million acquisition of the cataract laser company, in the wake of opposition from the US Federal Trade Commission (FTC). L...
3/20/2026
BreakingDry EyePharmaRegulation
US FDA Again Rejects Aldeyra’s Reproxalap for Dry Eye, Citing Trial Failures
Aldeyra Therapeutics reported March 17 that the US FDA had issued a third complete response letter rejecting the company’s new drug application (NDA) for topical reproxalap as a treatment for dry e...
3/20/2026
BreakingCorneal
Glaukos Launches Epioxa Epi-On Crosslinking Therapy for Keratoconus
Glaukos announced March 19 that its Epioxa, an epi-on version of the company’s corneal crosslinking therapy for keratoconus, was available to order directly from Glaukos or through its specialty ph...
3/20/2026
BreakingCataractGlaucomaLaserOptometryRegulationScope of Practice
New Law in Kansas Expands ODs’ Scope to Include Laser
Kansas has become the 15th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. House Bill 2223, signed into law by Gov. Laura Kelly on March 12, ...
3/20/2026
BiosimilarsBreakingEuropeRetina
Formycon Settlement Clears Way for Eylea Biosimilar in Europe, Other Markets
German companies Formycon and Klinge Biopharma reported March 19 that they had reached a settlement and license agreement with Regeneron and Bayer that clears the way for commercialization of Ahzan...
3/20/2026
BreakingChinaDeviceEmerging
Super Vision Gains China Approval of i-NYS Implant for Congenital Nystagmus
China-based Super Vision reported March 16 that its i-NYS implantable device forcongenital nystagmus had received market approval from China’s National Medical Products Administration (NMPA). Super...
3/20/2026
BreakingDiagnosticFundingOculomicsStudy
Amydis Wins $2.5 Million NIH Grant to Advance Retinal Tracer for ALS
Amydis, of San Diego, California, announced March 11 that it had been awarded $2.5 million from the National Institutes of Health (NIH) to advance a retinal tracer that could foster earlier detecti...
3/20/2026
BreakingDiagnosticDigital
Heru’s New PretestPro for VR Headset Runs Four Visual Exams in Under 2 Minutes
Ophthalmic wearable diagnostic company Heru recently unveiled its PretestPro, which the company says can run four visual exams in under two minutes. The company showcased the system March 11-14 at ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.